RAFAEL HOLDINGS, INC. Amortization of Debt Issuance Costs and Discounts
RAFAEL HOLDINGS, INC. (RFL) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2023-07-31, per its 10-K filed 2023-10-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2023-10-30
- RAFAEL HOLDINGS, INC. amortization of debt issuance costs and discounts for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- RAFAEL HOLDINGS, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $472.00K, a 1585.71% increase from fiscal 2021.
- RAFAEL HOLDINGS, INC. amortization of debt issuance costs and discounts for fiscal 2021 was $28.00K.
- RAFAEL HOLDINGS, INC. amortization of debt issuance costs and discounts for fiscal 2020 was $0.00.
| Period end | Amortization of Debt Issuance Costs and Discounts 12 month | Amortization of Debt Issuance Costs and Discounts 12 month as first filed |
|---|---|---|
| 2023-07-31 | $0.00 10-K · filed 2023-10-30 | |
| 2022-07-31 | $472.00K 10-K · filed 2023-10-30 | |
| 2021-07-31 | $28.00K 10-K · filed 2022-10-31 | $27.78K 10-K · filed 2021-10-18 |
| 2020-07-31 | $0.00 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |